Aarti Drugs Ltd. (AARTIDRUGS)
Market Closed
10 Aug, 22:00
MSE XNSE Primary MSE ₹
421. 35
+5
+1.2009%
₹
- Market Cap
- P/E Ratio
4% Div Yield
10,224 Volume
- Eps
₹ 416.35
Previous Close Want to track AARTIDRUGS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aarti Drugs Ltd. (AARTIDRUGS) Statistics
Valuation metrics
Market Cap -
Enterprise value 43.66B
Trailing P/E (ttm) 19.88
Forward P/E -
PEG ratio 15.81
Price/Sales (ttm) 1.42
Price/Book (mrq) 2.45
Enterprise Value/Revenue 1.63
Enterprise Value/EBITDA 13.02
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 11.91K
Average volume (90 days) 9.44K
Price summary
52-Week low 318.6
52-Week high 534.15
Beta -
50-Day moving average 399.18
200-Day moving average 376.33
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 2
Trailing annual dividend yield 0.0048%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 4 Mar 2026
Ex-Dividend Date 9 Feb 2026
Last split factor 4:1
Last split Date 30 Sep 2020
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.07%
Operating margin 0.1%
Operational effectiveness
Return on assets 0.07%
Return on equity 0.13%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 293.37
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 20.95
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.66
Total debt (mrq) -
Total Debt/Equity (mrq) 0.37
Current ratio (mrq) 1.59%
Book value per share (mrq) 169.74
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
